Document is current
Any future updates will be listed below
-
Authors
Houlder, E. L. http://orcid.org/0000-0003-0448-6055
Costain, A. H.
Nambuya, I.
Brown, S. L.
Koopman, J. P. R. http://orcid.org/0000-0003-1335-9402
Langenberg, M. C. C.
Janse, J. J.
Hoogerwerf, M. A.
Ridley, A. J. L.
Forde-Thomas, J. E.
Colombo, S. A. P.
Winkel, B. M. F.
Galdon, A. A.
Hoffmann, K. F. http://orcid.org/0000-0002-3932-5502
Cook, P. C.
Roestenberg, M. http://orcid.org/0000-0002-5052-2830
Mpairwe, H.
MacDonald, A. S. http://orcid.org/0000-0002-5356-1149
-
Funding
Funding for this research was provided by:
RCUK | Biotechnology and Biological Sciences Research Council
GCRF IAA MCCIR Core funding
- License Information
-
More Information
Article History
Received: 30 June 2022
Accepted: 17 March 2023
First Online: 3 April 2023
Competing interests
: The Manchester Collaborative Centre for Inflammation Research is a joint venture between the University of Manchester and GSK. The authors working at the MCCIR (A.S.M., E.L.H., A.H.C., S.L.B., A.J.L.R., P.C.C., A.A.G., S.A.C.) declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The remaining authors declare no competing interests.
